Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-30 @ 10:38 PM
Study NCT ID:
NCT00308750
Status:
COMPLETED
Last Update Posted:
2021-05-13
First Post:
2006-03-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
10651
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None